Both SNAP and Alzheimer’s disease continuum groups had greater CSF p-tau (181P) and CSF GAP-43 levels relative to the no Alzheimer’s disease pathology group. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.